原发性肝癌患者血清β2-微球蛋白含量变化的临床意义

刘强; 潘光栋; 褚光平; 杨建青

原发性肝癌患者血清β2-微球蛋白含量变化的临床意义

广西医科大学第五附属医院柳州市人民医院

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2031
- HTML全文浏览量: 14
- PDF下载量: 835
- 被引次数: 0
出版历程
- 出版日期: 2009-04-20

摘要

摘要: 目的探讨原发性肝癌患者血清β2-微球蛋白（β2-microglobulin,β2-MG）含量变化及临床应用价值。方法用免疫放射分析法（RIA）检测64例原发性肝癌患者、55例肝硬化、以及48例正常健康人血清β2-MG含量;动态检测原发性肝癌手术前后β2-MG含量变化。结果原发性肝癌组血清中β2-MG含量明显高于健康对照组（P<0.05）和肝硬化组（P<0.05）;原发性肝癌术前血清β2-MG含量增高者,术后含量明显降低,有转移复发时,β2-MG含量再度升高。结论检测血清β2-MG含量变化在原发性肝癌辅助诊断以及疗效、复发判断方面具有重要临床意义。
- 肝癌 /
- β2-微球蛋白
Abstract: Objective To study the clinical evaluation of serum β2-MG in hepatocarcinoma.Methods By using RIA, the levels of serum β2-MG of the health adults, patients with hepatocarcinoma, liver cirrhosis (LC) , operative patients before and after operation.Results Serum β2-MG levels of hepatocarcinoma are higher than that of the health adults, patients with LC, In health adults and patients with LC there is no significantly difference of β2-MG.The high Serum β2-MG levels in preoperative patients were reduced dramatically after operation (P<0.01) , however, the reduced Serum β2-MG levels raised again when matastasis or recurrence occurred.Serum β2-MG is a singly tumor marker.Conclusion The examination of serum β2-MG is helpful to the differential diagnose in hepatocarcinoma and LC;and has important significance in judgement of therapeutic effects and relapse for hepatocarcinoma
- hepatocarcinoma /
- β2-microglobulin

HTML全文

参考文献(6)

[1]Cao MG.Melanoma inhibiting activity protein (MIA) , beta-2microglobulin and lactate dehydrogenase (LDH) in metastatic mela-noma[J].Anticancer Res, 2007, 27 (11) ∶595-599.

[2]Fujiwara K, Higashi T, Nouso K, et al.Decreased expression ofB7 costimulatory mole-cules and major histocompatibility complexclass-I in human hepatocellular carcinoma[J].J GastroenterolHepatol.2004, 19 (10) ∶1121-1127.

[3]Obermann S, Petrykowska S, Manns MP, et al.Peptide-beta2-microglobulin-major histocompatibility complexexpressing cells arepotent antigen-presenting cells that can generate specific Tcells[J].Immunology, 2007, 122 (1) ∶90-97.

[4]Prasanna SJ, Nandi D.The MHC-encoded class I molecule, H-2Kk, demonstrates distinct requirements of assembly factors for cellsurface expression∶roles of TAP, Tapasin and beta2-microglobu-lin[J].Mol Immunol, 2004, 41 (10) ∶1029-1045.

[5]Ward DG, Cheng Y, N'Kontchou G, et al.Preclinical and post-treatment changes in the HCC-associated serum proteome[J].Br J Cancer, 2006, 95 (10) ∶1379-1380.

[6]王凯, 袁孟彪, 王东盛, 等.β2微球蛋白对原发性肝癌鉴别诊断的价值[J].临床肝胆病杂志, 2002, 18 (5) ∶286-287.

施引文献

资源附件(0)

访问统计